Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

Molecular basis for adaptation of a chimeric dengue type-4/Japanese encephalitis virus to Vero cells.

Tang WF, Eshita Y, Tadano M, Morita K, Makino Y.

Microbiol Immunol. 2005;49(3):285-94.

2.

Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses.

Pletnev AG, Bray M, Huggins J, Lai CJ.

Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10532-6.

3.

Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus.

Chang GJ, Hunt AR, Holmes DA, Springfield T, Chiueh TS, Roehrig JT, Gubler DJ.

Virology. 2003 Feb 1;306(1):170-80.

4.

West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy.

Pletnev AG, Putnak R, Speicher J, Wagar EJ, Vaughn DW.

Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3036-41. Erratum in: Proc Natl Acad Sci U S A 2002 May 14;99(10):7184.

5.

A trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4.

Hanley KA, Manlucu LR, Gilmore LE, Blaney JE Jr, Hanson CT, Murphy BR, Whitehead SS.

Virology. 2003 Jul 20;312(1):222-32.

6.

Chimeric Japanese encephalitis virus/dengue 2 virus infectious clone: biological properties, immunogenicity and protection against dengue encephalitis in mice.

Chambers TJ, Jiang X, Droll DA, Liang Y, Wold WS, Nickells J.

J Gen Virol. 2006 Nov;87(Pt 11):3131-40.

PMID:
17030845
8.

Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone.

Zhao Z, Date T, Li Y, Kato T, Miyamoto M, Yasui K, Wakita T.

J Gen Virol. 2005 Aug;86(Pt 8):2209-20.

PMID:
16033968
9.
10.
11.

Genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells.

Blaney JE Jr, Johnson DH, Manipon GG, Firestone CY, Hanson CT, Murphy BR, Whitehead SS.

Virology. 2002 Aug 15;300(1):125-39.

12.

Nucleotide sequence of envelope protein of Japanese encephalitis virus SA14-14-2 adapted to vero cells.

Hong SP, Yoo WD, Putnak R, Eckels KH, Rho HM, Kim SO.

DNA Seq. 2001 Dec;12(5-6):437-42.

PMID:
11913793
14.

E/NS1 modifications of dengue 2 virus after serial passages in mammalian and/or mosquito cells.

Chen WJ, Wu HR, Chiou SS.

Intervirology. 2003;46(5):289-95.

PMID:
14555849
15.

Mutations which enhance the replication of dengue virus type 4 and an antigenic chimeric dengue virus type 2/4 vaccine candidate in Vero cells.

Blaney JE Jr, Manipon GG, Firestone CY, Johnson DH, Hanson CT, Murphy BR, Whitehead SS.

Vaccine. 2003 Oct 1;21(27-30):4317-27.

PMID:
14505914
16.

Alterations of pr-M cleavage and virus export in pr-M junction chimeric dengue viruses.

Keelapang P, Sriburi R, Supasa S, Panyadee N, Songjaeng A, Jairungsri A, Puttikhunt C, Kasinrerk W, Malasit P, Sittisombut N.

J Virol. 2004 Mar;78(5):2367-81.

17.

Construction and preliminary investigation of a novel dengue serotype 4 chimeric virus using Japanese encephalitis vaccine strain SA14-14-2 as the backbone.

Li Z, Yang H, Yang J, Lin H, Wang W, Liu L, Zhao Y, Liu L, Zeng X, Yu Y, Li Y.

Virus Res. 2014 Oct 13;191:10-20. doi: 10.1016/j.virusres.2014.07.017. Epub 2014 Aug 1.

PMID:
25091563
18.

Construction and biological properties of yellow fever 17D/dengue type 1 recombinant virus.

Mateu GP, Marchevsky RS, Liprandi F, Bonaldo MC, Coutinho ES, Dieudonné M, Caride E, Jabor AV, Freire MS, Galler R.

Trans R Soc Trop Med Hyg. 2007 Mar;101(3):289-98. Epub 2006 Dec 12.

PMID:
17169387
19.
20.

Comparative sequences of two type 1 dengue virus strains possessing different growth characteristics in vitro.

Ishak H, Takegami T, Kamimura K, Funada H.

Microbiol Immunol. 2001;45(4):327-31.

Supplemental Content

Support Center